Cerus Endovascular today said it received CE mark approval for its CerusEndo MC 021 microcatheter.
The microcatheter is designed to allow physicians to access torturous neurovasculature and deliver therapeutic device to intended targets.
“We remain committed to meeting the ever-increasing needs of the interventional neuroradiologist community, and with that in mind, our team has clearly identified a range of increased performance demands required of a go-to intracranial access microcatheter,” president Stephen Griffin said in a news release. “As a result, we have expanded our key 021 platform so that it can deliver a wider range of devices than it was originally designed for including stents, braided flow diverters and stentrievers, for treatment of both hemorrhagic and ischemic strokes. In particular, the 021 ensures predictable stability and control when delivering larger and braided devices through the device lumen.”
Microcatheters are small diameter catheters that are used in minimally invasive procedures for delivering devices. Its small build makes it ideal for navigating complex vasculature within the human body.
“The systematic expansion of our market reach through the ever-increasing accumulation of regulatory approvals is part of our go-to-market strategy,” chairperson Sam Milstein said. “As previously announced, we will continue a limited market release in selected sites, beginning later this year. We are extremely pleased by the response of the medical community to our product portfolio.”
